Document is current
Any future updates will be listed below
-
Authors
Bouriez, Damien https://orcid.org/0000-0003-4039-9469
Belaroussi, Yaniss
Boubaddi, Mehdi
Martre, Paul
Najah, Haythem
Berger, Patrick
Gronnier, Caroline
Collet, Denis
- License Information
-
More Information
Article History
Received: 25 August 2021
Accepted: 7 February 2022
First Online: 22 June 2022
Declarations
:
: The authors Drs. Damien Bouriez, Yaniss Belaroussi, Mehdi Boubaddi, Paul Martre, Haythem Najah, Caroline Gronnier, and Denis Collet declare that they have no conflicts of interest or financial ties. Patrick Berger declares the following conflicts of interest outside the submitted work. P. Berger also reports grants and personal fees from AstraZeneca and Novartis; grants, personal fees, and non-financial support from Boehringer Ingelheim; personal fees and non-financial support from Chiesi, AstraZeneca, and Sanofi; personal fees from Menarini and TEVA. In addition, he has a delivered patent (EP N°15152886.6, i.e. New compositions and methods of treating and/or preventing Chronic Obstructive Pulmonary Disease), a submitted patent (22605-FR, i.e. Geometric characterization of airways using MRI), and a submitted patent (EP N°20173595.8, i.e. New compositions and methods of treating COVID-19 Disease)).
